Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 6 ( June, 2022 ) > List of Articles

PAEDIATRIC CRITICAL CARE

Risk Factors for Candida Infection among Children Admitted to a Pediatric Intensive Care Unit in a Tertiary Care Centre in Southern India

Raja Rajeshwari, Siva Vyasam, Jolly Chandran, Sanketh Porwal, Kala Ebenezer, Muniya Thokchom, Ebor J James, Reka Karuppusami

Keywords : Candida, Pediatric intensive care unit, Risk factors

Citation Information : Rajeshwari R, Vyasam S, Chandran J, Porwal S, Ebenezer K, Thokchom M, James EJ, Karuppusami R. Risk Factors for Candida Infection among Children Admitted to a Pediatric Intensive Care Unit in a Tertiary Care Centre in Southern India. Indian J Crit Care Med 2022; 26 (6):717-722.

DOI: 10.5005/jp-journals-10071-24203

License: CC BY-NC 4.0

Published Online: 20-06-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background: To describe the clinical profile, risk factors, and outcomes that are associated with candida infection among critically ill children. Patients and methods: A retrospective case-control study wherein 109 children admitted to the pediatric intensive care unit (PICU) in the years between 2015 and 2017 with the growth of candida from blood, urine, endotracheal (ET) aspirate, and pus swabs were included and compared to 97 age and sex-matched controls chosen from the same time period. Results: Of the 124 candida isolates from 109 children, 37% were from blood, 24% from urine, and 14% in pus; 40% of the isolates were from ET aspirate. Candida non-albicans types (70%) predominated with Candida tropicalis causing 50% of the infections. Risk factors for candida infection were neutropenia [OR 20.01, 95% CI (0.94–422.32)], mechanical ventilation [OR 5.97, 95% CI (2.44–14.62)], peritoneal dialysis [OR 5.81, 95% CI (1.27–26.50)], institution of amino acids [OR 5.41, 95% CI (0.85–34.13)], presence of central venous catheter [OR 3.83, 95% CI (1.59–9.19)], antibiotic use >5 days [OR 3.58, 95% CI (1.38–9.29)]. Candida Cases (95.4%) had a septic shock with acute kidney injury in 34% and had significantly lower survival than controls [72 (66%) of 109 vs. 74 (80%) of 92] (p = 0.023). Conclusions: The rate of candida infection in our PICU was 4.2% of PICU admissions. The most common species was C. tropicalis. The independent risk factors for candida infection were neutropenia, antibiotic duration >5 days, peritoneal dialysis, amino acid administration, mechanical ventilation, and presence of a central venous catheter (CVC).


PDF Share
  1. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 2014;5(1):161–169. DOI: 10.4161/viru.26187.
  2. ElGendy FM, Hassan FM, Khatab AA, El-Hendawy GR, Saleh NY. Study of fungal infections in pediatric intensive care unit in Menoufiya University Hospital. Menoufia Med J 2014;27(1):55. DOI: 10.4103/1110-2098.132742.
  3. Mesini A, Bandettini R, Caviglia I, Fioredda F, Amoroso L, Faraci M, et al. Candida infections in paediatrics: results from a prospective single-centre study in a tertiary care children's hospital. Mycoses 2017;60(2):118–123. DOI: 10.1111/myc.12570.
  4. Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, et al. Fungal Infection Network of Switzerland (FUNGINOS). Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study. J Infect 2018;76(05):489–495. DOI: 10.1016/j.jinf.2017.12.018.
  5. Harrington R, Kindermann SL, Hou Q, Taylor RJ, Azie N, Horn DL. Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients. Curr Med Res Opin 2017;33(10):1803–1812. DOI: 10.1080/03007995.2017.1354824.
  6. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36(5):309–332. DOI: 10.1016/j.ajic.2008.03.002.
  7. Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, et al.; Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009;123(5):1360–1368. DOI: 10.1542/peds.2008-2055.
  8. Devrim İ, Demirağ B, Yaman Y, Bayram N, Özdemir F, Kara A, et al. A 7-year study of the distribution of nosocomial candidemia in children with cancer. Turk J Pediatr 2015;57(3):225–229. PMID: 26701939.
  9. Almooosa Z, Ahmed GY, Omran A, AlSarheed A, Alturki A, Alaqeel A, et al. Invasive candidiasis in pediatric patients at King Fahad Medical City in Central Saudi Arabia. A 5-year retrospective study. Saudi Med J 2017;38(11):1118–1124. DOI: 10.15537/smj.2017.11.21116.
  10. Singhi S, Rao DSVR, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008;9(1):91–95. DOI: 10.1097/01.PCC.0000298643.48547.83.
  11. Conde-Rosa A, Amador R, Pérez-Torres D, Colón E, Sánchez-Rivera C, Nieves-Plaza M, et al. Candidemia distribution, associated risk factors, and attributed mortality at a university-based medical center. P R Health Sci J 2010;29(1):26–29. PMID: 20222330.
  12. Brissaud O, Guichoux J, Harambat J, Tandonnet O, Zaoutis T. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care 2012;2(1):6. DOI: 10.1186/2110-5820-2-6.
  13. Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010;51(5): e38–e45. DOI: 10.1086/655698.
  14. Aslan N, Yildizdas D, Alabaz D, Horoz OO, Yontem A, Kocabas E. Invasive candida infections in a pediatric intensive care unit in Turkey: evaluation of an 11-year period. J Pediatr Intensive Care 2020;9(1):21. DOI: 10.1055/s-0039-1695061.
  15. Acar A, Oncul O, Kucukardali Y, Ozyurt M, Haznedaroglu T, Cavujlu S. Epidemiological features of candida infections detected in intensive care units and risk factors affecting mortality. Mikrobiyol Bul 2008;42(3):451–461. PMID: 18822889.
  16. Sütçü M, Acar M, Genç GE, Kökçü İ, Aktürk H, Atay G, et al. Evaluation of Candida species and antifungal susceptibilities among children with invasive candidiasis. Turk Pediatr Ars 2017;52(3):145–153. DOI: 10.5152/TurkPediatriArs.2017.5291.
  17. Delisle MS, Williamson DR, Albert M, Perreault MM, Jiang X, Day AG, et al. Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia. Can Respir J 2011;18(3):131–136. DOI: 10.1155/2011/827692.
  18. De Pascale G, Antonelli M. Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer? Intensive Care Med 2014;40(9):1381–1384. DOI: 10.1007/s00134-014-3364-y.
  19. Dramowski A, Cotton MF, Whitelaw A. Surveillance of healthcare-associated infection in hospitalised South African children: which method performs best? South Afr Med J 2017;107(1):56–63. DOI: 10.7196/SAMJ.2016.v107.i1.11431.
  20. Palazzi DL, Arrieta A, Castagnola E, Halasa N, Hubbard S, Brozovich AA, et al. Candida speciation, antifungal treatment and adverse events in pediatric invasive candidiasis: results from 441 infections in a prospective, multinational study. Pediatr Infect Dis J 2014;33(12): 1294–1296. DOI: 10.1097/INF.0000000000000431.
  21. Çekin Y, Pekintürk N, Çekin AH. Evaluation of species distribution and antifungal resistance of Candida isolates from hospitalized patients. J Clin Anal Med 2015;6(97):8–11. DOI: 10.4328/JCAM.1638.
  22. Hazırolan G, Yıldıran D, Baran I, Mumcuoğlu İ, Aksu N. Yatan hasta örneklerinden izole edilen Candida izolatlarının tür dağılımlarının ve antifungal duyarlılık profillerinin değerlendirilmesi. Turk Hij Den Biyol Derg 2015;72(1):17–26. DOI: 10.5505/TurkHijyen.2015.75010.
  23. Mishra R, Behera C, Jena P, Mishra SN, Sahoo B, Patnaik S, et al. Candidemia in the pediatric intensive care unit in Eastern India. J Pediatr Crit Care 2020;7(5):237. DOI: 10.4103/JPCC.JPCC_38_20.
  24. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002;50(4):243–260. DOI: 10.1053/jhin.2001.1151.
  25. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:1–50. DOI: 10.1093/cid/civ933.
  26. Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, et al.; ESCMID Fungal Infection Study Group. ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 2012;18(Suppl 7): 38–52. DOI: 10.1111/1469-0691.12040.
  27. Hlophe ST, Govender NP, Masekela R. Invasive fungal infections among critically ill children: epidemiology, risk factors and outcomes. Afr J Thorac Crit Care Med 2018;24(1):11–14. DOI: 10.7196/AJTCCM.2018.v24i1.172.
  28. Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011;49(9):3300–3308. DOI: 10.1128/JCM.00179-11.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.